Home
AI
World
Politics
Health
Crime & justice
Science & technology
Social issues
Sports
Money
Entertainment
Environment/energy
Military
Culture
Weather
Media






Home
Bias Split
Public FiguresControversies

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

Sign Up!
Sign Up Now!

How our sliders workAboutContact UsNewsletter Archive
MediaFAQGlossaryPrivacy Policy
  1. Home

J&J Unit Files For Bankruptcy to Pursue $8.9B Talc Settlement

  • #Lawsuits
  • #Money
  • #Product liability
  • #Verdicts & sentences
story
APR 2023
Image copyright: Reuters
story last updated APR 2023

The Spin

Establishment-critical narrative

Big Pharma continues to get away with murder, while the FDA allows companies to conduct their own clinical trials free from proper oversight. When they inevitably create toxic products, the companies get slapped with an easy-to-pay fine, while no executives go to jail or even pay individual penalties. Unless there’s a crackdown, this cycle will continue.

Suffolk

Pro-establishment narrative

J&J, which isn't at fault, continues to be committed to producing the safest and most effective products. It only agreed to the settlement to avoid wasting time and money in a drawn-out court battle that would’ve resulted in nothing for the plaintiffs. Now J&J can return to the business of protecting people's health.

Content Lab U.S.

Articles on this story

J&J Can’t Use Bankruptcy to Resolve Talc-Injury Lawsuits, Appeals Court Rules
Wall Street JournalJUL 2023
Johnson & Johnson’s talc bankruptcy case rejected by appeals court
New York PostJUL 2023